Deutsche Bank Aktiengesellschaft Cuts Medical Properties Trust (NYSE:MPW) Price Target to $20.00

Medical Properties Trust (NYSE:MPWGet Rating) had its price objective dropped by stock analysts at Deutsche Bank Aktiengesellschaft from $25.00 to $20.00 in a research note issued to investors on Wednesday, The Fly reports. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 10.38% from the stock’s previous close.

Several other equities analysts also recently weighed in on the company. Bank of America downgraded Medical Properties Trust from a “buy” rating to a “neutral” rating and set a $21.00 target price on the stock. in a research report on Friday, March 11th. Jefferies Financial Group downgraded Medical Properties Trust from a “buy” rating to a “hold” rating and cut their price objective for the company from $25.00 to $20.00 in a research report on Friday, April 22nd. Mizuho upped their price objective on Medical Properties Trust from $23.00 to $26.00 in a research report on Thursday, January 20th. Truist Financial cut their price objective on Medical Properties Trust from $26.00 to $23.00 and set a “hold” rating on the stock in a research report on Thursday, March 24th. Finally, StockNews.com began coverage on Medical Properties Trust in a research report on Thursday, March 31st. They issued a “hold” rating on the stock. Six equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $23.10.

NYSE:MPW opened at $18.12 on Wednesday. The company has a market cap of $10.80 billion, a price-to-earnings ratio of 16.47, a PEG ratio of 1.66 and a beta of 0.58. The company has a debt-to-equity ratio of 1.34, a current ratio of 3.99 and a quick ratio of 3.99. The stock’s 50 day simple moving average is $20.37 and its two-hundred day simple moving average is $21.41. Medical Properties Trust has a 1 year low of $18.07 and a 1 year high of $24.13.

Medical Properties Trust (NYSE:MPWGet Rating) last released its earnings results on Thursday, February 3rd. The real estate investment trust reported $0.34 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.46 by ($0.12). The company had revenue of $409.30 million for the quarter, compared to the consensus estimate of $403.73 million. Medical Properties Trust had a net margin of 42.47% and a return on equity of 7.83%. The business’s revenue for the quarter was up 22.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.41 EPS. As a group, analysts anticipate that Medical Properties Trust will post 1.87 EPS for the current year.

In related news, Director Michael G. Stewart sold 6,000 shares of the company’s stock in a transaction on Thursday, March 10th. The stock was sold at an average price of $20.26, for a total transaction of $121,560.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO R Steven Hamner sold 285,000 shares of the company’s stock in a transaction on Thursday, April 7th. The stock was sold at an average price of $21.04, for a total value of $5,996,400.00. Following the sale, the chief financial officer now owns 1,961,214 shares of the company’s stock, valued at $41,263,942.56. The disclosure for this sale can be found here. Insiders sold a total of 906,000 shares of company stock valued at $19,235,910 over the last quarter. Company insiders own 1.04% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Dark Forest Capital Management LP purchased a new stake in shares of Medical Properties Trust during the 3rd quarter worth $26,000. Moors & Cabot Inc. purchased a new stake in Medical Properties Trust in the third quarter valued at about $27,000. Mystic Asset Management Inc. purchased a new stake in Medical Properties Trust in the fourth quarter valued at about $27,000. Sageworth Trust Co of South Dakota purchased a new stake in Medical Properties Trust in the fourth quarter valued at about $36,000. Finally, Exane Derivatives raised its stake in Medical Properties Trust by 542.6% in the fourth quarter. Exane Derivatives now owns 1,748 shares of the real estate investment trust’s stock valued at $41,000 after buying an additional 1,476 shares during the last quarter. Hedge funds and other institutional investors own 80.77% of the company’s stock.

Medical Properties Trust Company Profile (Get Rating)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis.

Recommended Stories

The Fly logo

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.